BARCELONA, Spain--(BUSINESS WIRE)--INBRAIN Neuroelectronics S.L., a company in the intersection between Medtech, Deeptech and Digital Health dedicated to developing the world’s first intelligent ...
BARCELONA, Spain, December 09, 2025--(BUSINESS WIRE)--INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced ...
BARCELONA, Spain, April 20, 2026--(BUSINESS WIRE)--INBRAIN Neuroelectronics, a neurotechnology company developing graphene-based brain-computer interface therapeutics (BCI-Tx), today announced ...
Elon Musk's Neuralink has a new competitor It's a startup company called Inbrain Neuroelectronics It says its chips are made of one of the strongest materials ever tested It aims to cure brain ...
INBRAIN Neuroelectronics, a Graphene Flagship spin-off company, has been named Spain’s most innovative company by leading Spanish news publication El Periódico. INBRAIN exists to decode and modulate ...
InBrain Neuroelectronics’ brain-computer interface (BCI) has been implanted in the first patient in a clinical trial, as the company looks to use its graphene technology beyond brain signal decoding.
Graphene-based BCI demonstrates high-resolution brain decoding and mapping in patients undergoing tumor resection at the Manchester Centre for Clinical Neurosciences Initial four patient cohort has ...
We are thrilled to announce the publication of the first paper in Neuroelectronics, a new journal dedicated to pioneering research at the intersection of neuroscience, electronic systems, and neural ...
Neuroelectronics Research Flanders (NERF) has the following research output in the current window (1 February 2025 - 31 January 2026) of the Nature Index. Click on Count to view a list of articles ...
The study (NCT06368310), sponsored by the University of Manchester and conducted with Northern Care Alliance NHS Foundation Trust, evaluated INBRAIN’s graphene-based cortical interface during ...
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced the appointment of Scott Huennekens as Chairman of its ...